New therapies for obesity: efficacy and safety of GLP-1 agonists. Research, Society and Development, [S. l.], v. 14, n. 1, p. e10514148004, 2025. DOI: 10.33448/rsd-v14i1.48004. Disponível em: https://rsdjournal.org/rsd/article/view/48004. Acesso em: 5 dec. 2025.